7/12

Tackling myopia together through global partnerships

EssilorLuxottica’s commitment to lessening the impact of myopia in children is stronger than ever, and partnerships with key global players are helping to make positive changes.

Nearly five billion people could suffer from myopia by 2050, making it one of the biggest threats facing vision, and the way forward requires real change based on a multidisciplinary approach through collaboration.

As a leader in vision care, EssilorLuxottica is deeply involved in the fight against myopia, developing breakthrough innovations, such as the Essilor Stellest lens, which slows down myopia progression in children by 67% on average, compared to single vision lenses when worn 12 hours a day*, and creating valuable partnerships with leading global organizations to truly affect positive change and help make a much-needed impact on children’s lives everywhere. In addition, EssilorLuxottica and CooperCompanies will leverage their shared expertise and global leadership in myopia management to accelerate the commercialization of SightGlass Vision spectacle lenses, which slow down the progression of myopia in children.

Tackling myopia together through global partnerships

 

A firm believer in the power of collaboration, the Company is a platinum sponsor of the International Myopia Institute (IMI), a consensus body of global myopia experts, and co-sponsor of its 2021 white papers on myopia. EssilorLuxottica also partners with Myopia Profile, a leading international myopia educational company, to jointly raise public awareness of myopia and empower eye care practitioners with clinical knowledge, skills and practical resources in managing childhood myopia. In addition, as a founding member of the industry-wide Global Myopia Awareness Coalition (GMAC), the Company – along with other leading industry players and eye health associations – promotes public awareness of childhood myopia, its prevention and new myopia management solutions.

Moving forward, EssilorLuxottica will continue to expand its partnerships globally to better understand pathways for myopia onset and progression, advance innovative solutions, and help educate and equip all healthcare professionals to better manage myopia together.

 

* Compared to single vision lenses, when worn 12 hours a day. Two-year prospective, controlled, randomized, double-masked clinical trial results on 54 myopic children wearing Essilor Stellest lenses compared to 50 myopic children wearing single vision lenses. Efficacy results based on 32 children who declared wearing Essilor Stellest lenses at least 12 hours per day every day. Bao J. et al. (2021). Myopia control with spectacle lenses with aspherical lenslets: a 2-year randomized clinical trial. Invest. Ophthalmol. Vis. Sci.; 62(8):2888. Essilor and Stellest are trademarks of Essilor.